OTCM
BTAX
Market cap16kUSD
Oct 08, Last price
0.00USD
IPO
-99.79%
Name
Immune Therapeutics Inc
Chart & performance
P/E
—
P/S
—
EPS
—
Div yield, %
—
Shrs. gr., 5y
157.47%
Rev. gr., 5y
134.52%
Revenues
0
Net income
-6m
L
CFO
-582k
L+151.09%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Immune Therapeutics, Inc. currently conducts no significant business operations. Formerly known as TNI BioTech, Inc., the company adopted its present name in October 2014. Its corporate headquarters are situated in Orlando, Florida.
Key people
Nicholas Plotnikoff
Non-Executive Chairman of the Board · since 2012
Peter Aronstam
Chief Financial Officer · since 2013
Rudy Williams
Chief Operating Officer · since 2017
Fengping Shan
Chief Science Officer · since 2014
Christopher Pearce
Director · since 2017
Kevin J. Phelps
Director · since 2019
Paul Akin
Independent Director · since 2016
Edward Teraskiewicz
Independent Director · since 2015
Legal address
C/O CORPORATE CREATIONS NETWORK, INC.
801 US HWY 1
PALM BEACH, FL 33408
US
801 US HWY 1
PALM BEACH, FL 33408
US
Headquarters
2774 East Colonial Drive
C #1100
Orlando, FL 32803
US
C #1100
Orlando, FL 32803
US
Previous name
PH Environmental Inc
Previous name
TNI BioTech, Inc.
Previous name
Resort Clubs International, Inc.
Previous name
Immune Therapeutics, Inc.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||
Revenues | |||||||
Cost of revenue | |||||||
Unusual Expense (Income) | |||||||
NOPBT | |||||||
NOPBT Margin | |||||||
Operating Taxes | |||||||
Tax Rate | |||||||
NOPAT | |||||||
Net income | |||||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
| Debt | |||||||
Debt current | |||||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | |||||||
| Cash flow | |||||||
Cash from operating activities | |||||||
CAPEX | |||||||
Cash from investing activities | |||||||
Cash from financing activities | |||||||
FCF | |||||||
| Balance | |||||||
Cash | |||||||
Long term investments | |||||||
Excess cash | |||||||
Stockholders' equity | |||||||
Invested Capital | |||||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | |||||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | |||||||
EV/EBITDA | |||||||
Interest | |||||||
Interest/NOPBT | |||||||